• Explore /
  • Poster
  • / Validation of PD-L1 as a predictive biomarker of response in operable gastroesophageal adenocarcinoma: A meta-analysis and meta-regression of neoadjuvant chemoimmunotherapy trials.

Validation of PD-L1 as a predictive biomarker of response in operable gastroesophageal adenocarcinoma: A meta-analysis and meta-regression of neoadjuvant chemoimmunotherapy trials.

Abstract Poster

Authors

null

Antonella Cammarota

Sarah Cannon Research Institute UK, London, London, United Kingdom

Antonella Cammarota , Sivesh Kathir Kamarajah , Sheraz Markar , Elizabeth Catherine Smyth

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer - Local-Regional Disease

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 4065)

DOI

10.1200/JCO.2024.42.16_suppl.4065

Abstract #

4065

Poster Bd #

45

Abstract Disclosures

Similar Posters

First Author: Antonio D'Alessio

First Author: Nour Abuhadra

First Author: Ronan Andrew Mc Laughlin

First Author: Daisuke Takahari